Psilocybin May Shield Nerves From Chemotherapy, Mouse Study Suggests
A mouse study published in Science found that psilocybin, given before chemotherapy, can prevent chemotherapy-induced peripheral neuropathy by preserving mitochondrial trafficking and ATP production in nerve endings. The protective effect relies on the serotonin receptor 5-HT2A, and a non-hallucinogenic 5-HT2A activator also provided protection. Human trials have not yet proven efficacy, though researchers plan to move toward clinical testing.
